Renal artery denervation has been recently re-included in the European Society of Cardiology’s recommendations as a potential treatment option for carefully selected patients suffering from hypertension. According to a KUL press release, the procedure has shown potential in helping to reduce blood pressure and, in some instances, decrease the overall dosage of prescribed medications. A key emphasis from medical experts, such as cardiologist Aistė Šalkauskaitė-Rubliauskienė at KUL, is the critical importance of proper patient selection.
She clarifies that the procedure is not intended to be the initial line of treatment for high blood pressure. Instead, it is reserved for cases where standard, established management measures have not yielded the expected therapeutic results. The consensus among specialists suggests that management of hypertension must follow a structured, escalating approach.
Therefore, only those patients who have exhausted conventional therapies are considered candidates for this intervention. This guideline underscores a commitment to evidence-based care, ensuring that advanced procedures are utilized judiciously. For individuals managing chronic hypertension, adherence to regular cardiology check-ups remains paramount.
Medical professionals advise that consistent monitoring and lifestyle modifications should always form the foundation of care, with denervation serving as a targeted intervention for select, refractory cases.
Topics: #patients #who #blood
This is promising news for patients struggling to control their blood pressure.